Apures Co., Ltd. (XKON:149300)

Market Cap	2.41B
Revenue	n/a
Net Income	n/a
Shares Out	45.49M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	74,670
Open	55.00
Previous Close	55.00
Day's Range	55.00 - 55.00
52-Week Range	41.00 - 487.00
Beta	-0.45
RSI	33.59
Earnings Date	n/a

About Apures

Apures Co., Ltd. engages in the development and commercialization of solutions for the bio and medical industries in South Korea. It is involved in the development of MICROPIG, which are research and laboratory mini pig species to provide solutions through standardization of biomaterials for medical experiments and development of regenerative medicine treatments, including cell therapy and heterogeneous organs. The company provides Porcine Primary Cell for in vitro test; and heterogeneous organ technology, a technology that develops and transpl...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 149300